Government Opioid Settlement Funds Used For Mobile Opioid Treatment Vehicles And Mobile Medical Clinics At Quality Vans & Specialty Vehicles
By deploying mobile opioid treatment clinics, organizations can reach at-risk populations who may not have access to brick-and-mortar facilities. Our mobile medical vehicles are designed to be a safe, private, and effective space for treatment and education, helping to remove barriers to care and reduce opioid-related harm" said Luke Alm from Quality Vans & Specialty Vehicles.
Each custom-built unit can be equipped with exam rooms, private consultation areas, medication dispensing stations, secure storage for medical supplies, solar power and more. These mobile medical vehicles are tailored to meet the needs of each program, whether serving rural communities, urban neighborhoods, or disaster relief areas where opioid intervention is critical.
In addition to opioid treatment vehicles, QVSV is assisting with public outreach vehicles that focus on education, overdose prevention training, and community engagement. These mobile units provide information on naloxone (Narcan) distribution, safe disposal of prescription drugs, and access to recovery services.
As the opioid crisis continues to impact families nationwide, Quality Vans & Specialty Vehicles is committed to delivering solutions that help save lives. By partnering with municipalities, healthcare providers and public health initiatives, QVSV is playing a vital role in expanding treatment accessibility and ensuring that settlement funds are used effectively to combat the epidemic.
Example video of a mobile medical vehicle:
For more information on mobile opioid treatment vehicles or trailers, visit
SOURCE Quality Vans & Specialty Vehicles
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment